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ABSTRACT The gastric bacterium Helicobacter pylori causes a persistent infection
that is directly responsible for gastric ulcers and gastric cancer in some patients and
protective against allergic and other immunological disorders in others. The two
outcomes of the Helicobacter-host interaction can be modeled in mice that are in-
fected as immunocompetent adults and as neonates, respectively. Here, we have in-
vestigated the contribution of the Helicobacter immunomodulator VacA to H. pylori-
speciﬁc local and systemic immune responses in both models. We found that
neonatally infected mice are colonized at higher levels than mice infected as adults
and fail to generate effector T-cell responses to the bacteria; rather, T-cell responses
in neonatally infected mice are skewed toward Foxp3-positive (Foxp3) regulatory T
cells that are neuropilin negative and express RORt. We found these peripherally
induced regulatory T cells (pTregs) to be enriched, in a VacA-dependent manner, not
only in the gastric mucosa but also in the lungs of infected mice. Pulmonary pTreg
accumulation was observed in mice that have been infected neonatally with wild-
type H. pylori but not in mice that have been infected as adults or mice infected
with a VacA null mutant. Finally, we traced VacA to gastric lamina propria myeloid
cells and show that it suppressed interleukin-23 (IL-23) expression by dendritic cells
and induced IL-10 and TGF- expression in macrophages. Taken together, the results
are consistent with the idea that H. pylori creates a tolerogenic environment through
its immunomodulator VacA, which skews T-cell responses toward Tregs, favors H. py-
lori persistence, and affects immunity at distant sites.
IMPORTANCE Helicobacter pylori has coexisted with humans for at least 60.000 years
and has evolved persistence strategies that allow it to evade host immunity and col-
onize its host for life. The VacA protein is expressed by all H. pylori strains and is re-
quired for high-level persistent infection in experimental mouse models. Here, we
show that VacA targets myeloid cells in the gastric mucosa to create a tolerogenic
environment that facilitates regulatory T-cell differentiation, while suppressing effec-
tor T-cell priming and functionality. Tregs that are induced in the periphery during
H. pylori infection can be found not only in the stomach but also in the lungs of in-
fected mice, where they are likely to affect immune responses to allergens.
KEYWORDS T-cell immunity, T cells, dendritic cells, host-cell interactions,
immunomodulation, mucosal infection, regulatory T cells, macrophages
Infection with the gastric bacterium Helicobacter pylori is associated with a range ofgastric disorders that include peptic ulcers and gastric cancer but is now also known
to have systemic consequences for the host that manifest at distant sites. For example,
infected children exhibit reduced growth rates and suffer more commonly from anemia
than their uninfected counterparts and, on the other hand, show reduced susceptibility
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to atopy and allergic conditions in general (1–3). Helicobacter eradication by combina-
tion therapy with two to three antibiotics is a viable and cost-efﬁcient strategy to
reduce gastric cancer risk; however, not all carriers of H. pylori beneﬁt equally from the
successful eradication of H. pylori (4, 5). In particular, subgroup analyses of adults
presenting with preneoplastic lesions at the time of eradication therapy show differ-
ential rates of treatment success. Only patients with atrophic or nonatrophic gastritis,
and not patients that have progressed to metaplasia or dysplasia, appear to beneﬁt
from eradication therapy through reduced gastric cancer risk (5), although this notion
was recently challenged by a study showing that H. pylori eradication may still reduce
the risk of development of metachronous gastric cancer in patients who have already
undergone endoscopy for early gastric cancer (6). As infected children are much less
likely to develop H. pylori-related symptoms than infected adults (7), routine eradication
therapy (“test and treat”) is not recommended in this age group (8). Furthermore,
children are more likely to beneﬁt from harboring H. pylori, and eradication of the
infection in children is projected to incur a signiﬁcant cost. The identiﬁcation of
biomarkers that allow accurate predictions of who will beneﬁt from eradication therapy
and who will not, and of who will progress along the path to gastric cancer and who
will not, therefore is widely considered to be of high priority. Attempts have been made
to stratify patients based on the frequencies in blood of regulatory T cells (Tregs),
especially of the subset of Tregs expressing the anti-inﬂammatory cytokine
interleukin-10 (IL-10) (9). That work showed that high frequencies of IL-10-positive
(IL-10) Tregs in the circulation of H. pylori carriers were inversely associated with
allergen-speciﬁc IgE concentrations and that blocking of IL-10 in vitro restored IgE
responses (9). An earlier study had already pointed to IL-10 Treg responses in the
stomach as being predictive of asymptomatic carriage of H. pylori; in contrast, low Treg
counts and high frequencies of Th1 and Th2 responses were associated with peptic
ulcers (10). Such protective Treg responses are particularly characteristic of infected
children, who generally present with fewer symptoms, lower levels of histologically
evident pathology, and more pronounced Treg responses than adult counterparts
infected with similarly aggressive H. pylori strains (7). High numbers of gastric IL-10
Tregs in children have been linked to reduced Th17 responses to the infection, which
may well account for the reduced immunopathology in that age group (11). The
immunophenotypic data from infected children and adults align well with observations
from epidemiological studies on asthma and allergy risk in relation to H. pylori infection.
In this context, H. pylori confers a stronger protective effect in children than in adults,
and early-onset asthma shows a particularly strong inverse correlation with H. pylori
infection (12, 13). The stronger inverse association of asthma with H. pylori in children
than in adults was conﬁrmed in several meta-analyses (14).
Previous work in our laboratory provided experimental evidence from mouse mod-
els that link early-life H. pylori exposure to sustained protection against ovalbumin- or
house dust mite (HDM)-induced allergic airway inﬂammation (15–17), dextran sulfate
sodium (DSS)-induced colitis (18), and peanut- or ovalbumin-induced food allergy (19).
The protective effects are either not seen at all or are much weaker in mice infected as
adults (15). We have further reported that early-life exposure to H. pylori induces
immune tolerance, driven by Foxp3 Tregs, that prevents immunopathology and
excessive effector T-cell responses to the infection and permits high-level (asymptom-
atic) colonization (20). The neonatal infection model thus phenocopies several aspects
of the host/H. pylori interaction in children and asymptomatic carriers (7, 10, 11) and
lends itself to mechanistic studies and biomarker discovery. We and others have used
the neonatal and adult infection models to identify both host and H. pylori determi-
nants that promote immune tolerance; Treg induction; and high-level, persistent
colonization. The H. pylori immunomodulators gamma-glutamyl-transpeptidase (gGT)
and vacuolating cytotoxin (VacA) have emerged as critical factors shaping the outcome
of H. pylori infection. Interestingly, both proteins are secreted and act on T cells as well
as myeloid cells to prevent T-cell activation and function on the one hand (21, 22) and
to induce tolerogenic activities in dendritic cells (DCs) on the other (23, 24). Infection
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of mice with H. pylori strains deﬁcient in either of the two immunomodulators is
associated with improved immune control and clearance (24–26) and with a reduced
capability of DCs to prime Treg differentiation in the periphery, relative to infection of
mice with wild-type (WT) H. pylori strains. Both gGT and VacA can be used in puriﬁed
or recombinant form to reduce the severity of allergy symptoms in prophylactic
settings, provided that the proteins are administered early in life (27).
Here, we set out to identify immune correlates of, and to gain mechanistic insights
into, the differential responses of neonatal and adult mice to H. pylori strains that either
express the VacA protein or not. We use tracking strategies and multicolor ﬂow
cytometry of leukocyte populations in the gastric mucosa and the lung (a distant site
at which protective effects of gastric H. pylori infection are detected) to quantify
differential myeloid and T-cell responses as a function of age at ﬁrst exposure and of
VacA expression. We show here that neonatal and adult infected mice differ in their
predominant T-cell responses to the infection and that VacA acts directly on macro-
phages and DCs to promote the differentiation and maintenance of Tregs but not of
Th17 cells; the effects of gastric H. pylori colonization are further evident in the lungs
of neonatal but not adult infected mice even prior to allergen exposure and shape
allergen-speciﬁc immune responses at this distant site.
RESULTS
VacA promotes immune tolerance by skewing gastric T-cell responses in favor
of peripherally induced RORt regulatory T cells. We showed earlier that a
VacA-expressing H. pylori strain, but not its isogenic null mutant, is capable of sup-
pressing gastric H. pylori-speciﬁc effector T-cell responses and maintaining high-level
persistent colonization (24). To investigate in more detail whether VacA proﬁciency and
the age of the mice at the time of infection affect gastric T-cell responses, we
conducted a multicolor ﬂow cytometric analysis of gastric lamina propria (LP) T-cell
populations of mice that had been infected at 7 days or 6 weeks of age (neonatal or
adult infection, respectively) with wild-type H. pylori or its isogenic VacA-deﬁcient
mutant. Whereas neonatally infected mice were characterized by high-level coloniza-
tion but no detectable CD4 T-cell inﬁltration, their counterparts that had been
infected as immunocompetent adults were colonized at lower levels and showed
strong CD4 T-cell recruitment (Fig. 1A and B; see also Fig. S1A in the supplemental
material). VacA-deﬁcient bacteria colonized mice at signiﬁcantly lower levels than the
parental strain in both the neonatal and the adult infection model but showed similar
levels of CD4 T-cell inﬁltration overall (Fig. 1A and B). Staining for intracellular IL-17
and for the transcription factor RORt revealed robust Th17-polarized effector T-cell
responses in the adult infection scenario that were largely absent in neonatally infected
mice (Fig. 1C and D; see also Fig. S1B). In contrast, neonatally infected mice exhibited
higher frequencies of Foxp3 regulatory T cells (Tregs), a result that was at least partly
dependent on VacA (Fig. 1E). Both peripherally induced, neuropilin-negative pTregs
and thymus-derived, neuropilin-positive tTregs were somewhat overrepresented in
neonatally infected mice (Fig. 1F and G). The differences in pTreg frequencies between
adult and neonatally infected mice on the one hand and between wild-type (WT) and
VacA mutant-infected mice on the other were largely attributable to the RORt-positive
pTreg subset (Fig. 1H), which represents the dominant pTreg subset in the gastric LP
after H. pylori infection (see schematic in Fig. S1A). The results indicate that VacA
expression by the bacteria and the age at the time of infection both have a strong
impact on T-cell recruitment and polarization as well as on infection control.
VacA targets macrophages and dendritic cells in the gastric lamina propria. To
address how, and through which cell types, VacA contributes to T-cell skewing and
immunomodulation, we ﬁrst assessed which leukocyte populations are targeted by
VacA in the gastric LP. Our attempts at tracking VacA secreted by live bacteria were
futile, as the only VacA-speciﬁc antiserum we have at our disposal that detects the
native protein was raised against the s1m1 variant of VacA (28); our mouse-colonizing
H. pylori PMSS1 strain expresses the s2m2 VacA variant that is not well detected by the
VacA Interacts with Myeloid Cells and Promotes Tregs ®
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FIG 1 Gastric T-cell responses in mice infected neonatally with VacA-proﬁcient H. pylori are skewed in favor
of peripherally induced RORt regulatory T cells. C57BL/6 mice were infected at either 7 days of age (i.e.,
were infected neonatally [iN]) or 6 weeks of age (i.e., were infected as adults [iA]) with H. pylori PMSS1 or
its isogenic VacA-deﬁcient mutant (ΔVacA), and colonization levels and gastric lamina propria (LP) T-cell
responses were analyzed by FACS 6 weeks later. (A) H. pylori (H.p.) colonization, as assessed by plating and
colony counting. (B) Frequencies of CD4 T cells among all live LP cells of the mice as indicated in panel
A along with uninfected controls. (C) Frequencies of RORt Foxp3 cells among all CD4 T cells. (D)
Frequencies of IL-17 CD4 T cells, as assessed by restimulation with PMA/ionomycin, followed by
intracellular cytokine staining. (E) Frequencies of Foxp3 regulatory T cells (Tregs) among all CD4 T cells.
(Continued on next page)
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serum. Therefore, we resorted to a strategy that involved oral gavage of mice with
puriﬁed H. pylori s1m1 VacA, followed by the ﬂow cytometric analysis of VacA signals
in various leukocyte populations of the gastric LP at 12 and 36 h postadministration.
VacA could be traced to three myeloid populations, i.e., F4/80-positive macrophages,
CD11b DCs, and CD103 DCs (see Fig. S2A for the gating strategy used for the
identiﬁcation of these populations), at both 12 and 36 h postadministration (Fig. 2A to
C), but the signals faded thereafter (data not shown). VacA-positive cells were relatively
rare among all macrophage and DC populations, with frequencies generally under 10%,
but signals were clearly discernible and not observed in untreated mice (Fig. 2A to C).
To examine whether VacA is also sampled by antigen-presenting cells in the lower
gastrointestinal (GI) tract, we harvested Peyer’s patches and analyzed them for possible
VacA signals. CD8 and, to a lesser extent, CD11b DCs, but no other DC, and no
other myeloid populations of that lymphoid tissue, showed evidence of VacA positivity
at 12 h postadministration (Fig. 2D to F); ﬂuorescently labeled ovalbumin, which served
as a model antigen and positive control, showed similar kinetics and distributions in
Peyer’s patches (Fig. S2B).
VacA has immunomodulatory activities not only when it is delivered in the context
of a live infection but also when administered orally or intraperitoneally (i.p.) to pups
early in life (19, 27). To mimic this scenario and monitor the fate of VacA in the
peritoneum over time, we subjected mice to i.p. injection once with 20 g of puriﬁed
VacA, isolated peritoneal macrophages 2, 6, and 16 h later by peritoneal lavage, and
subjected the cells to VacA staining. Two predominant, developmentally distinct sub-
sets of macrophages (termed “small” and “large” peritoneal macrophages) (29) were
retrieved using this procedure and were found to be strongly positive for VacA at 2 and
6 h postadministration, with signals fading at 16 h postdelivery (Fig. S2C). To study the
transcriptional signature of macrophages that have been exposed to VacA in vivo, we
isolated large and small peritoneal macrophages from mice that had been treated for
6 h with either wild-type VacA protein or an inactive VacAΔ6–27 mutant protein (which
is defective in membrane channel formation due to absence of a hydrophobic domain
near the N terminus of the protein) (30, 31). Wild-type VacA, but not the mutant,
induced the expression of several examined genes in both large and small macro-
phages, including those encoding the cytokines tumor necrosis factor alpha (TNF-),
IL-10, and IL-6, as well as the enzyme cyclooxygenase 2 (COX2; encoded by the PTGS2
gene) (Fig. S2D and E). The response of macrophages was consistent with a mixed
response consisting of both pro- and anti-inﬂammatory mediators. The combined data
suggest that VacA targets myeloid cells in its natural environment, i.e., the gastric
mucosa and Peyer’s patches, and also targets peritoneal macrophages in an interven-
tional setting designed to promote immune tolerance.
VacA suppresses IL-23 expression by gastric CD11b DCs and induces IL-10
and TGF- expression by macrophages. Naïve T cells differentiate into RORt-
positive Th17 cells if they are exposed to their corresponding cognate antigen on
antigen-presenting cells in environments that are rich in IL-6 and TGF-. A third
Th17-promoting cytokine, IL-23, acts to maintain Th17 differentiation but is not re-
quired during the priming phase in lymph nodes. We have shown previously that H.
pylori encounters monocytes and macrophages as well as CD11b DCs, but not
CD103 DCs, in the gastric LP as judged by tracking of an red ﬂuorescent protein
(RFP)-expressing H. pylori strain (32). All three populations are recruited to the H.
pylori-infected gastric LP (32), and their levels of recruitment do not differ measurably
FIG 1 Legend (Continued)
(F) Frequencies of neuropilin-1-positive (Nrp-1) Foxp3 thymus-derived Tregs among all CD4 T cells. (G)
Frequencies of Nrp-1 Foxp3 peripherally induced Tregs (pTregs) among all CD4 T cells. (H) Frequencies
of RORt Nrp-1 pTregs among all CD4 T cells. Pooled data from two independent experiments are
shown throughout, with n 10 to 13 per condition. Horizontal lines indicate medians; statistical analyses
were done using ANOVA with Dunn’s multiple-comparison correction. *, P 0.05; **, P 0.01; ***,
P 0.005; ****, P 0.001. The gating strategy for Treg and effector T-cell populations is shown in Fig. S1.
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FIG 2 VacA associates with myeloid cells in the gastric lamina propria and the Peyer’s patches. Mice received a single dose of 20 g
of puriﬁed VacA by oral gavage and were sacriﬁced 12 or 36 h later. Gastric LP (A to C) and Peyer’s patch (D to F) single-cell
preparations were subjected to multicolor ﬂow cytometry with antibodies allowing the identiﬁcation of various myeloid cell
populations as well as an antiserum speciﬁc for VacA. (A to C) Frequencies of VacA-positive cells among F4/80 Ly6C Ly6G MHCII
macrophages (A), among CD11b CD103 F4/80 Ly6C Ly6G MHCII DCs (B), and among CD103 CD11b F4/80 Ly6C Ly6G
MHCII DCs (C) in the gastric LP. Frequencies are shown along with representative histograms. (D to F) Frequencies of VacA-positive
cells among CD8aCD11b MHCII CD11c DCs (D), among CD11bCD8a MHCII CD11c DCs (E), and among CD8a CD11b
MHCII CD11c double-negative (DN) DCs (F) in the Peyer’s patches. Frequencies are shown along with representative histograms.
Results presented in panels A to F are representative of three independently conducted experiments. Horizontal lines indicate
medians; statistical analyses were done using ANOVA with Dunn’s multiple-comparison correction. The gating strategy for myeloid
populations is shown in Fig. S2.
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if the infecting strain lacks VacA (data not shown). To assess whether VacA contributes
to cytokine production by dendritic cells or macrophages, we subjected pure popula-
tions of F4/80 CD11b DCs and F4/80 Ly6clo CX3CR1hi macrophages from LP
preparations of mice that had been infected neonatally with WT or ΔVacA H. pylori to
ﬂuorescence-activated cell sorter (FACS) analysis and determined their levels of expres-
sion of cytokines relative to cells from uninfected controls. We found several typical DC
cytokines, including IL-23, IL-12, IL-6, IL-10, and TGF-, to be upregulated in DCs from
infected mice; most of these were similarly highly expressed in DCs from WT and ΔVacA
H. pylori-infected mice (Fig. S3A and B and data not shown). One notable exception was
IL-23, which was expressed at signiﬁcantly higher levels in DCs from ΔVacA H. pylori-
infected stomachs than in DCs from WT H. pylori-infected stomachs (Fig. S3A and B).
Macrophages also exhibited VacA-dependent responses to H. pylori: only macrophages
sorted from LP preparations of mice that had been infected with WT but not with
ΔVacA H. pylori expressed IL-10 and TGF-, whereas the level of expression of IL-12 was
unaffected by the VacA status (Fig. 3A; see also Fig. S3C). A similar dependence of IL-10
induction in macrophages on VacA was observed in vitro with bone marrow-derived
macrophages infected with H. pylori, at both the transcript and protein levels (Fig. 3B
and C). A second strain of H. pylori expressing s1m1 VacA showed the same VacA
dependence regarding IL-10 induction (Fig. S3D). Furthermore, exposure to puriﬁed
s1m1 VacA was sufﬁcient to dose-dependently induce IL-10 expression and secretion in
macrophages in vitro (Fig. 3B and C). The combined results suggest that VacA modu-
lates the responses of DCs and macrophages to H. pylori, resulting in a milieu that
promotes Treg over Th17 differentiation and/or expansion.
Gastric infection with VacA-proﬁcient H. pylori skews lung T-cell populations
toward Th1 and regulatory T cells. H. pylori causes a strictly localized gastric infection
and is not known to spread to other parts of the body. Nevertheless, it has strong
modulatory properties that manifest in distant organs, especially the lung. VacA is one
of the major immunomodulatory molecules that contribute to the systemic effects of
H. pylori infection (19, 24, 27). In order to identify immunological correlates of the
reduced airway inﬂammation that is a hallmark of H. pylori-infected mice (15–17), we
proﬁled pulmonary T-cell populations of mice that had been infected as adults or as
neonates with H. pylori. Whereas the overall frequencies of pulmonary CD4 T cells
were not measurably affected by gastric H. pylori infection irrespective of the age at the
time of infection (Fig. 4A), we detected shifts in pulmonary Treg frequencies that were
consistent with those observed in the gastric LP. Interestingly, we found that the lungs
of mice that had been infected neonatally with wild-type H. pylori but not VacA mutant
H. pylori exhibited increased frequencies of Foxp3 Tregs, which, as in the case of the
gastric LP, could be attributed to the peripherally induced neuropilin-negative pTreg
subset (Fig. 4B to D). Frequencies of pulmonary neuropilin-positive tTregs were un-
changed (Fig. 4C). Mice that had been infected as adults rather than during early life did
not exhibit the described changes in pulmonary Treg cell populations (Fig. 4B) but
rather showed pulmonary T-cell skewing toward Th1 and Th17 cells (Fig. S4). The
combined results demonstrate that local infection of the gastric mucosa with H. pylori
has systemic consequences that manifest in the lung in the appearance of a population
of peripherally induced Tregs; this Treg population is seen only under conditions of
neonatal, tolerogenic H. pylori infection and depends on the immunomodulator VacA.
DISCUSSION
The objectives of this work were to (i) gain a detailed understanding of the function
of H. pylori VacA in immunity and immune tolerance to H. pylori and (ii) investigate the
mechanistic basis underlying the differential responses of neonatal and adult mice to
H. pylori. We have previously demonstrated in a model of H. pylori infection of adult,
immunocompetent mice that VacA is required for high-level persistent colonization
(24). Here, we have extended these ﬁndings to the neonatal infection model and show
that VacA promotes colonization under both conditions. We have further used a ﬂow
cytometric approach to trace VacA in the murine gastric mucosa; while sufﬁciently
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sensitive to detect orally administered, puriﬁed VacA even in rare myeloid cell popu-
lations, our highly speciﬁc and sensitive antiserum unfortunately did not allow tracking
of H. pylori-derived VacA in the context of a live infection with either strain PMSS1
(which expresses s2m2 VacA) or strain J166 (which expresses s1m1 VacA). Puriﬁed VacA
was taken up by gastric macrophages, as well as by two populations of DCs, i.e.,
CD103 BATF-dependent DCs and CD11b IRF4-dependent DCs. All three populations
are known to be recruited to the H. pylori-infected gastric mucosa (32). Gene expression
analysis of CD11b DCs and macrophages—the numerically most abundant of the
three myeloid populations—revealed clear differential responses to VacA-positive and
FIG 3 VacA activates IL-10 and TGF- expression by macrophages in the gastric LP. (A) CX3CR1/GFP mice
were infected at 7 days of age (iN) with H. pylori PMSS1 or its isogenic VacA-deﬁcient mutant (ΔVacA) and
sacriﬁced 6 weeks later. F4/80 Ly6Clo MHCII CX3CR1hi macrophages were sorted from gastric LP
preparations of individual mice and subjected to reverse transcriptase quantitative PCR (qRT-PCR)
analyses of Il10 (left) and Tgfb1 (right). Results shown in panel A were pooled from two independent
studies. Each symbol represents sorted cells from a single mouse. (B and C) Bone marrow-derived murine
macrophages were infected with H. pylori PMSS1 or its ΔVacA mutant at the indicated MOIs, or treated
with the indicated concentrations of puriﬁed VacA for 6 h. Cells were subjected to qRT-PCR analyses of
Il10 expression (B), and their supernatants were subjected to IL-10 quantiﬁcation by ELISA (C). Data in
panels B and C are representative of results from three independent studies. Means plus standard errors
of the means (SEM) are shown; statistical analyses were done using ANOVA with Dunn’s multiple-
comparison correction. *, P 0.05; **, P 0.01; ***, P 0.005; ****, P 0.001.
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–negative bacteria. In particular, we found that the level of expression of IL-23 by
CD11b DCs is suppressed in a VacA-dependent manner, which correlates well with the
higher frequencies of Th17 cells in the lamina propria of VacA mutant-infected relative
to WT-infected mice. CD11b DCs are known to drive Th17 differentiation and/or
maintenance (33), and IL-23 is a critical cytokine involved in the defense against
intestinal bacterial pathogens such as Citrobacter rodentium, with CD11b DCs serving
as a major source of IL-23 in the intestines (34). Our observation that VacA targets the
CD11b DC/IL-23/Th17 axis to maintain high-level persistent infection is consistent
with the results from the Citrobacter rodentium infection model and explains why a
ΔVacA mutant is controlled more efﬁciently in mice. In macrophages, the dominant
VacA-dependent effects on cytokine gene expression were observed for IL-10 and
TGF-, which were strongly induced only by VacA-expressing bacteria in vitro and in
vivo. TGF- in particular is well known to promote Treg differentiation in the periphery,
where TGF- signaling synergizes with microbial signals and retinoic acid to drive
Foxp3 expression in naive T cells (35, 36). Activation of the TGF- signaling pathway in
naive T cells leads to the binding of SMAD2 and SMAD3 to a response element, termed
conserved noncoding sequence 1 (CNS1), which is part of a Foxp3 intronic enhancer
and is known to regulate Foxp3 expression in pTregs (37). The combined data obtained
from gene expression analyses of macrophages and DCs are consistent with the notion
that VacA has evolved to create a tolerogenic setting, favoring pTreg induction and
preventing effector T-cell (especially Th17) responses. In the absence of VacA, an
IL-23/Th17 axis that is driven by CD11b DCs, and accompanied by reduced peripheral
FIG 4 Neonatal H. pylori infection is associated with a VacA-dependent systemic Treg response that
manifests in the lung. C57BL/6 mice were infected either at 7 days of age (i.e., were infected neonatally [iN])
or 6 weeks of age (i.e., were infected as adults [iA]) with H. pylori PMSS1 or its isogenic VacA-deﬁcient
mutant (ΔVacA), and pulmonary T-cell responses were analyzed by FACS 6 weeks later. (A) Frequencies of
CD4 T cells among all live cells. (B) Frequencies of Foxp3 Tregs among all CD4 T cells. (C) Frequencies
of Nrp-1 thymus-derived tTregs among all CD4 T cells. (D) Frequencies of Nrp-1 peripherally induced
pTregs among all CD4 T cells. Data pooled from two independent experiments are shown throughout,
with n 10 to 13 per condition. Horizontal lines indicate medians; statistical analyses were done using
ANOVA with Dunn’s multiple-comparison correction. *, P 0.05; **, P 0.01; ***, P 0.005; ****, P 0.001.
The gating strategy for pulmonary Tregs is the same as for gastric Tregs and is shown in Fig. S1.
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Treg differentiation, promotes infection control. Our data are in line with earlier studies
that have shown—using both in vitro coculture and adoptive DC transfer models—that
H. pylori exposure skews DC responses toward priming Treg over Th17 differentiation
(38, 39). We now link this activity of H. pylori to VacA in vitro and in vivo. VacA is one
of two H. pylori immunomodulators that target dendritic cells to promote immune
tolerance. The other factor is a secreted enzyme, -glutamyl-transpeptidase (gGT), that
drives the production of glutamate from glutamine (23). Glutamate then binds to
glutamate receptors expressed by dendritic cells, and the downstream signaling path-
way suppresses the expression of IL-6 and other proinﬂammatory cytokines by den-
dritic cells and boosts their ability to induce the expression of Foxp3, and of regulatory
cytokines, in cocultured naive T cells (23). We have no indication that the two pathways
of VacA- and gGT-driven immunomodulation are mutually dependent; rather, H. pylori
appears to have evolved the two factors independently. gGTs are expressed also by
other non-pylori Helicobacter species (40), whereas VacA expression is believed to be
restricted to gastric Helicobacter strains, such as H. felis (41).
The second objective of this work was to identify a plausible mechanism underlying
the differential responses of neonatal and adult mice to H. pylori. These differential
responses translate into vastly different outcomes of the Helicobacter-host interaction
(20) and are recapitulated in human carriers of H. pylori (10); therefore, reliable
biomarkers that would predict one outcome (benign coexistence) or the other (chronic
inﬂammation and the associated pathology) are urgently needed to guide rational
treatment decisions. The most striking differences in neonatal and adult infected mice
are observed in the T-cell compartment, with little if any T-cell and, especially, effector
T-cell inﬁltration apparent in the gastric mucosa of neonatally infected mice. As a
consequence, ratios of effector T cells to regulatory T cells differ radically as a conse-
quence of the age at the time of ﬁrst exposure. Strikingly, similar differences in the
T-cell compartment are observed in the lungs, where Tregs are overrepresented as a
consequence of neonatal but not adult infection. As shifts in the ratios of effector T cells
to Treg cells were detected in the lung and stomach, but not in the examined lymphoid
tissues (mesenteric lymph nodes and spleen, data not shown), we suspect that a special
connection must exist between these two tissues. Indeed, only neonatally infected but
not adult infected mice are protected against experimentally induced allergic airway
inﬂammation upon ovalbumin or house dust mite allergen exposure (15–17), and an
inverse association of H. pylori with allergic asthma is more evident in children or in
young adults than in older individuals in epidemiological studies (11, 12). Our data add
to a growing understanding of microbial effects on the so-called gut-lung axis, a
concept that stipulates that changes in the host microbiota, especially of the GI tract,
have effects on immunity in the lung (42). The idea of the existence of the gut-lung axis
is, for example, supported by the ﬁnding that antibiotic-induced alterations in the gut
microbiota in early life increase the risk of developing allergic airway disease (43, 44).
Metabolites, especially short-chain fatty acids such as acetate and butyrate, derived
from fermenting gut-resident microbes are known to affect the severity of allergic
airway inﬂammation in mouse models (45). In addition to microbial metabolites,
structural ligands of resident microbes, such as lipopolysaccharide (LPS) and pepti-
doglycan, especially when absorbed by or leaking into deeper tissues, are known to
inﬂuence circulating lymphocytes and contribute to the regulation of systemic immune
responses (42). H. pylori is unique in that it has evolved to avoid recognition by innate
immune receptors; its LPS is modiﬁed to evade detection by Toll-like receptor 4 (TLR4)
(46), and its ﬂagellin cannot be recognized by TLR5 due to a mutation in the TLR5-
binding domain (47). Rather, H. pylori expresses various immunomodulators, such as
the VacA protein, -glutamyl-transpeptidase, NapA protein, and others, to actively
interfere with either the maturation and function of antigen-presenting cells or directly
with T cells (21, 23, 24, 48, 49), affecting immunity not only locally at the site of infection
but also systemically and at distant sites.
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MATERIALS AND METHODS
Mice. C57BL/6 and CX3CR1/GFP mice were obtained from Janvier and the Jackson Laboratories and
were bred and maintained under speciﬁc pathogen-free conditions in accredited animal facilities at the
University of Zurich. All animal experimentation was reviewed and approved by the Zurich Cantonal
Veterinary Ofﬁce (licenses ZH24/2013, ZH170/2014, ZH224/2014, and ZH140/2017).
H. pylori infection and VacA puriﬁcation and treatment. The H. pylori PMSS1 strain used in this
study for in vivo experimentation is a clinical isolate from a patient with duodenal ulcer and the parental
strain of mouse-derivative Sydney strain 1 (SS1) (20). Its VacA-deﬁcient mutant has been described
previously (23). H. pylori cultures were grown on horse blood agar plates and in liquid culture as
described previously (20). Cultures were routinely assessed by light microscopy for contamination,
morphology, and motility. Mice were infected orally on two consecutive days with 107 CFU H. pylori
PMSS1 at 7 days or 6 weeks of age and analyzed 6 weeks later unless speciﬁed otherwise. H. pylori VacA
(WT or a Δ6-27 mutant protein) was puriﬁed from culture supernatants of H. pylori strain 60190
expressing streptavidin (Strep)-tagged s1m1 VacA via the use of a Strep Tactin resin as described
previously (50). VacA was either orally or intraperitoneally administered at a dose of 20 g/mouse.
Leukocyte isolation. For LP leukocyte isolation, gastrointestinal tissues were opened longitudinally,
washed, and cut into pieces. The pieces were incubated in phosphate-buffered saline (PBS)–10% bovine
serum albumin (BSA)–5 mM EDTA at 37°C to remove epithelial cells. Tissue was digested at 37°C for
30 min in a shaking incubator with 15 mM HEPES, 500 U/ml of type IV collagenase (Sigma-Aldrich), and
0.05 mgml1 DNase I in supplemented RPMI 1640 medium. Cells were then pushed through a cell
strainer and layered onto a 40%/80% Percoll gradient and centrifuged, and the interface was washed in
PBS–0.5% BSA. Peyer’s patch cell suspensions were prepared by pushing cells through a cell strainer
using a syringe plunger. Lung cell suspensions were prepared by perfusion of the lung with PBS, followed
by pushing the lung through a cell strainer.
Flow cytometry and T-cell restimulation. Cells were stained with a ﬁxable viability dye and a
combination of the following antibodies, including anti-mouse CD45 (clone 30-F11), CD11c (N418), major
histocompatibility complex class II (MHCII) (M5/114.15.2), F4/80 (BM8), CD103 (M2E7), CD11b (M1/70),
CD4 (RM4-5), neuropilin-1 (3E12), IL-17a (TC11-18H10.1), gamma interferon (IFN-) (XMG1.2), Ly6G (1A8),
Ly6C (HK1.4), or an IgG isotype control (all from BioLegend), as well as TIM3 (FAB1529P; R&D). Fc block
(anti-CD16/CD32; Affymetrix) was included to minimize nonspeciﬁc antibody binding. For intracellular
cytokine staining, the cells were incubated at 37°C for 3 h in complete IMDM medium containing 0.1 M
phorbol 12-myristate 13-acetate (PMA) and 1 M ionomycin with 1:1,000 brefeldin A (eBioscience) and
GolgiStop solutions (BD Biosciences) at 37°C in a humidiﬁed incubator with 5% CO2. For the intranuclear
staining of transcription factors, cells were ﬁxed and permeabilized with a Foxp3/transcription factor
staining buffer set (eBioscience) after surface staining was performed according to the manufacturer’s
instructions. Cells were stained for 50 min with antibodies to FoxP3 (FJK-16s), RORt (B2D) from
Invitrogen, and Tbet (4B10) (from Biolegend). For VacA-speciﬁc staining, samples were ﬁxed and
permeabilized and stained with a rabbit antiserum speciﬁc for s1m1 VacA, which was described
previously (28). Samples were acquired on a LSRII Fortessa ﬂow cytometer (BD Biosciences) or sorted on
an Aria III cell sorter (BD Biosciences) and analyzed using FlowJo software.
In vitro macrophage cultures and infection. Bone marrow cells were harvested from the femurs of
multiple donor mice, seeded at 106 cells/well in 1 ml of RPMI medium–10% FCS–penicillin (Pen)–
streptavidin (Strep) and cultured with 20 ng/ml macrophage colony-stimulating factor (M-CSF) (Pepro-
Tech) for 6 days. Cells were washed and infected with H. pylori PMSS1 or H. pylori PMSS1 ΔVacA, G27, or
G27ΔVacA at multiplicities of infection (MOIs) of 50 and 100 for 6 h or treated with 1 or 10 g/ml puriﬁed
VacA; supernatants were harvested and analyzed by IL-10 enzyme-linked immunosorbent assay (ELISA),
and RNA from cells was isolated by the use of an RNeasy minikit (Qiagen) according to the manufacturer’s
instructions.
Quantitative PCR. RNA was isolated from FACS-sorted cells using an RNeasy minikit (Qiagen)
according to the manufacturer’s instructions. cDNA synthesis was performed using SuperScript III reverse
transcriptase (Qiagen). Quantitative PCRs for the candidate genes were performed using TaqMan gene
expression assays as follows: for Hprt, Mm03024075_m1; for Tgfb1, Mm01178820_m1; for IL-10,
Mm01288386_m1; for IL-23, Mm00518984_m1; for Il6, Mm00446190_m1; for Ptgs2, Mm00478374_m1;
for Tnf, Mm00443258_m1; for IL-12b, Mm01288989_m1) (all from Applied Biosystems by Thermo Fisher
Scientiﬁc). cDNA samples were analyzed in duplicate using a Light Cycler 480 detection system (Roche),
and gene expression levels were normalized to hypoxanthine phosphoribosyltransferase (HPRT) expres-
sion for each sample. Mean relative gene expression levels were determined, and the differences were
calculated using the threshold cycle (2ΔCT) method.
Statistical analysis. Statistical analysis was performed with Prism 6.0 (GraphPad Software).
One-way analysis of variance (ANOVA) followed by pairwise comparisons and Dunn’s multiple
comparison correction was used for all statistical comparisons of three or more groups. Differences
were considered statistically signiﬁcant with P values of 0.05 (*, P 0.05; **, P 0.01; ***,
P 0.005; ****, P 0.001).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00261-19.
FIG S1, TIF ﬁle, 4.3 MB.
FIG S2, TIF ﬁle, 2.5 MB.
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FIG S3, TIF ﬁle, 4 MB.
FIG S4, TIF ﬁle, 1.3 MB.
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